{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:57:15Z","timestamp":1790963835641,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009781","name":"Robert Lundbergs Minnesstiftelse","doi-asserted-by":"publisher","award":["Project grant"],"award-info":[{"award-number":["Project grant"]}],"id":[{"id":"10.13039\/501100009781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["24-3694; 22-2108"],"award-info":[{"award-number":["24-3694; 22-2108"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["23-2853"],"award-info":[{"award-number":["23-2853"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["25-4486"],"award-info":[{"award-number":["25-4486"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["24-3842"],"award-info":[{"award-number":["24-3842"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2015-00162"],"award-info":[{"award-number":["2015-00162"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Radiumhemmets Forskningsfonder","doi-asserted-by":"publisher","award":["251202; 231172"],"award-info":[{"award-number":["251202; 231172"]}],"id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The epidermal growth factor receptor (EGFR) is a well-established oncogenic driver in multiple epithelial cancers, yet its role in breast cancer remains elusive, with EGFR-targeted therapies showing limited clinical efficacy. Here, we demonstrate that EGFR promotes selective lymphatic dissemination in triple-negative breast cancer through a chemotactic mechanism involving the EGFR ligand TGF-\u03b1. Lymphatic endothelial cells (LECs) were identified as a tumor-associated source of TGF-\u03b1, both in a murine model and in human breast cancer, particularly upon stimulation with TGF-\u03b21, a cytokine commonly overexpressed in breast tumors associated with lymph metastasis. We found that TGF-\u03b1\u2013EGFR interactions elicit directional migration via STAT3 signaling, whereas the co-secreted ligand CTGF, enriched in blood endothelial cells, suppressed migration. Pharmacologic blockade of TGF-\u03b1 with Fepixnebart, a first-in-class ligand-neutralizing antibody targeting TGF-\u03b1 and previously not tested in oncologic indications, significantly inhibited early lymph metastasis of EGFR\u207a tumor cells. Furthermore, EGFR overexpression resulted in increased cellularity in tumor-draining lymph nodes and reduced CD8\u207a T-cell representation. Together, these findings reveal a role for the TGF-\u03b1\/EGFR axis in lymph metastasis and propose a rationale for repositioning EGFR-targeted therapies toward targeting early metastatic spread and immunomodulation in breast cancer.<\/jats:p>","DOI":"10.1038\/s41523-026-00941-0","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:05:42Z","timestamp":1775196342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TGF-\u03b1\/EGFR-mediated lymphatic metastasis reveals a repositionable therapeutic target in breast cancer"],"prefix":"10.1038","volume":"12","author":[{"given":"Wenyang","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavik","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Helleday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria H.","family":"Ulvmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Windahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael C. I.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Fuxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"941_CR1","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1056\/NEJMra0707704","volume":"358","author":"F Ciardiello","year":"2008","unstructured":"Ciardiello, F. & Tortora, G. EGFR antagonists in cancer treatment. N. Engl. J. Med. 358, 1160\u20131174 (2008).","journal-title":"N. Engl. J. Med."},{"key":"941_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrc3309","volume":"12","author":"Y Yarden","year":"2012","unstructured":"Yarden, Y. & Pines, G. The ERBB network: at last, cancer therapy meets systems biology. Nat. Rev. Cancer 12, 553\u2013563 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"941_CR3","doi-asserted-by":"crossref","unstructured":"Yarden Y., Sliwkowski M. X., Yarden Y., Sliwkowski M. X. Untangling the ErbB signalling network. Nat.Rev. Mol. Cell Biol. 2 (2001).","DOI":"10.1038\/35052073"},{"key":"941_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccr.2014.02.025","volume":"25","author":"CL Arteaga","year":"2014","unstructured":"Arteaga, C. L. & Engelman, J. A. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell 25, 282\u2013303 (2014).","journal-title":"Cancer Cell"},{"key":"941_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10549-012-2289-9","volume":"136","author":"H Masuda","year":"2012","unstructured":"Masuda, H. et al. Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res. Treat. 136, 331\u2013345 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"941_CR6","doi-asserted-by":"crossref","unstructured":"Wee P., Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers. 9 (2017).","DOI":"10.3390\/cancers9050052"},{"key":"941_CR7","doi-asserted-by":"crossref","unstructured":"Dickler M. N. et al. A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer. Clin. Cancer Res. 14, (2008).","DOI":"10.1158\/1078-0432.CCR-08-0141"},{"key":"941_CR8","doi-asserted-by":"crossref","unstructured":"Wendt M. K. et al. The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6. Neoplasia. 17 (2015).","DOI":"10.1016\/j.neo.2014.11.009"},{"key":"941_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn7983","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Sci. Adv. 8, eabn7983 (2022).","journal-title":"Sci. Adv."},{"key":"941_CR10","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/1878-0261.12494","volume":"13","author":"SI Mohammed","year":"2019","unstructured":"Mohammed, S. I., Torres-Luquis, O., Walls, E. & Lloyd, F. Lymph-circulating tumor cells show distinct properties to blood-circulating tumor cells and are efficient metastatic precursors. Mol. Oncol. 13, 1400\u20131418 (2019).","journal-title":"Mol. Oncol."},{"key":"941_CR11","doi-asserted-by":"crossref","unstructured":"Reticker-Flynn, N. E. et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell. 185 (2022).","DOI":"10.1016\/j.cell.2022.04.019"},{"key":"941_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/1878-0261.13047","volume":"16","author":"IH Rye","year":"2022","unstructured":"Rye, I. H. et al. Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression. Mol. Oncol. 16, 88\u2013103 (2022).","journal-title":"Mol. Oncol."},{"key":"941_CR13","first-page":"78","volume":"45","author":"B Sidhu","year":"2018","unstructured":"Sidhu, B. et al. American Joint Committee on Cancer (AJCC) cancer staging eighth edition: prognostic vs anatomic path stage group for breast cancer. J. Registry Manag 45, 78\u201379 (2018).","journal-title":"J. Registry Manag"},{"key":"941_CR14","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/1878-0261.12092","volume":"11","author":"MC Karlsson","year":"2017","unstructured":"Karlsson, M. C., Gonzalez, S. F., Welin, J. & Fuxe, J. Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system. Mol. Oncol. 11, 781\u2013791 (2017).","journal-title":"Mol. Oncol."},{"key":"941_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck, R., Turley, S. J. & Akhurst, R. J. TGFbeta biology in cancer progression and immunotherapy. Nat. Rev. Clin. Oncol. 18, 9\u201334 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"941_CR16","first-page":"613","volume":"29","author":"J Chod","year":"2008","unstructured":"Chod, J. et al. Preoperative transforming growth factor-beta 1 (TGF-beta 1) plasma levels in operable breast cancer patients. Eur. J. Gynaecol. Oncol. 29, 613\u2013616 (2008).","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"941_CR17","doi-asserted-by":"crossref","unstructured":"Giotopoulou N. et al. TGF\u00df1 Stimulates Lymphatic Endothelial Cells to Produce IL7 and IL15, Which Act as Chemotactic Factors for Breast Cancer Cells with Mesenchymal Properties. J. Mammary Gland Biol. Neoplasia 28 (2023).","DOI":"10.1007\/s10911-023-09552-y"},{"key":"941_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/onc.2015.133","volume":"35","author":"MF Pang","year":"2016","unstructured":"Pang, M. F. et al. TGF-beta1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7\/CCL21-mediated chemotaxis. Oncogene 35, 748\u2013760 (2016).","journal-title":"Oncogene"},{"key":"941_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3389\/fimmu.2019.00518","volume":"10","author":"RH Farnsworth","year":"2019","unstructured":"Farnsworth, R. H., Karnezis, T., Maciburko, S. J., Mueller, S. N. & Stacker, S. A. The interplay between lymphatic vessels and chemokines. Front Immunol. 10, 518 (2019).","journal-title":"Front Immunol."},{"key":"941_CR20","doi-asserted-by":"crossref","unstructured":"Liu T. et al. Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients. Nat. Commun. 13 (2022).","DOI":"10.1038\/s41467-022-34581-2"},{"key":"941_CR21","doi-asserted-by":"crossref","unstructured":"Schust J., Sperl B., Hollis A., Mayer T. U., Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 13 (2006).","DOI":"10.1016\/j.chembiol.2006.09.018"},{"key":"941_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1124\/jpet.113.210765","volume":"349","author":"CB Beidler","year":"2014","unstructured":"Beidler, C. B. et al. Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-alpha and epiregulin. J. Pharm. Exp. Ther. 349, 330\u2013343 (2014).","journal-title":"J. Pharm. Exp. Ther."},{"key":"941_CR23","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/pro.3023","volume":"25","author":"JS Boyles","year":"2016","unstructured":"Boyles, J. S., Atwell, S., Druzina, Z., Heuer, J. G. & Witcher, D. R. Structural basis of selectivity and neutralizing activity of a TGFalpha\/epiregulin specific antibody. Protein Sci. 25, 2028\u20132036 (2016).","journal-title":"Protein Sci."},{"key":"941_CR24","doi-asserted-by":"crossref","unstructured":"Beidler C. B. et al. Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-\u03b1 and epiregulin. J. Pharmacol. Exp. Therapeutics. 349 (2014).","DOI":"10.1124\/jpet.113.210765"},{"key":"941_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/cpdd.436","volume":"7","author":"J Sloan-Lancaster","year":"2018","unstructured":"Sloan-Lancaster, J. et al. Evaluation of the safety, pharmacokinetics, pharmacodynamics, and efficacy after single and multiple dosings of LY3016859 in healthy subjects and patients with diabetic nephropathy. Clin. Pharm. Drug Dev. 7, 759\u2013772 (2018).","journal-title":"Clin. Pharm. Drug Dev."},{"key":"941_CR26","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen, T. O. et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin. Cancer Res. 10, 5367\u20135374 (2004).","journal-title":"Clin. Cancer Res."},{"key":"941_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2016.42","volume":"2","author":"R Ali","year":"2017","unstructured":"Ali, R. & Wendt, M. K. The paradoxical functions of EGFR during breast cancer progression. Signal Transduct. Target Ther. 2, 16042 (2017).","journal-title":"Signal Transduct. Target Ther."},{"key":"941_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/427695a","volume":"427","author":"TP Padera","year":"2004","unstructured":"Padera, T. P. et al. Pathology: cancer cells compress intratumour vessels. Nature 427, 695 (2004).","journal-title":"Nature"},{"key":"941_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5715","volume":"5","author":"E Lee","year":"2014","unstructured":"Lee, E. et al. Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis. Nat. Commun. 5, 4715 (2014).","journal-title":"Nat. Commun."},{"key":"941_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep05853","volume":"4","author":"E Lee","year":"2014","unstructured":"Lee, E., Pandey, N. B. & Popel, A. S. Lymphatic endothelial cells support tumor growth in breast cancer. Sci. Rep. 4, 5853 (2014).","journal-title":"Sci. Rep."},{"key":"941_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/574025","volume":"2012","author":"ZI Khamis","year":"2012","unstructured":"Khamis, Z. I., Sahab, Z. J. & Sang, Q. X. Active roles of tumor stroma in breast cancer metastasis. Int J. Breast Cancer 2012, 574025 (2012).","journal-title":"Int J. Breast Cancer"},{"key":"941_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.semcdb.2015.01.008","volume":"38","author":"ER Pereira","year":"2015","unstructured":"Pereira, E. R., Jones, D., Jung, K. & Padera, T. P. The lymph node microenvironment and its role in the progression of metastatic cancer. Semin Cell Dev. Biol. 38, 98\u2013105 (2015).","journal-title":"Semin Cell Dev. Biol."},{"key":"941_CR33","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1167\/iovs.09-4386","volume":"51","author":"JL McClintock","year":"2010","unstructured":"McClintock, J. L. & Ceresa, B. P. Transforming growth factor-alpha enhances corneal epithelial cell migration by promoting EGFR recycling. Investig. Ophthalmol. Vis. Sci. 51, 3455\u20133461 (2010).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"941_CR34","first-page":"e28086","volume":"3","author":"Y Teng","year":"2014","unstructured":"Teng, Y., Ross, J. L. & Cowell, J. K. The involvement of JAK-STAT3 in cell motility, invasion, and metastasis. JAKSTAT 3, e28086 (2014).","journal-title":"JAKSTAT"},{"key":"941_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-0527-z","volume":"18","author":"JH Ma","year":"2020","unstructured":"Ma, J. H., Qin, L. & Li, X. Role of STAT3 signaling pathway in breast cancer. Cell Commun. Signal 18, 33 (2020).","journal-title":"Cell Commun. Signal"},{"key":"941_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/421821","volume":"2013","author":"MZ Kamran","year":"2013","unstructured":"Kamran, M. Z., Patil, P. & Gude, R. P. Role of STAT3 in cancer metastasis and translational advances. Biomed. Res. Int. 2013, 421821 (2013).","journal-title":"Biomed. Res. Int."},{"key":"941_CR37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41416-022-01838-y","volume":"127","author":"D Konishi","year":"2022","unstructured":"Konishi, D. et al. Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma. Br. J. Cancer 127, 757\u2013765 (2022).","journal-title":"Br. J. Cancer"},{"key":"941_CR38","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.1007\/s00018-021-03873-z","volume":"78","author":"L Gillot","year":"2021","unstructured":"Gillot, L., Baudin, L., Rouaud, L., Kridelka, F. & Noel, A. The pre-metastatic niche in lymph nodes: formation and characteristics. Cell Mol. Life Sci. 78, 5987\u20136002 (2021).","journal-title":"Cell Mol. Life Sci."},{"key":"941_CR39","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras, L., Shaashua, L., Matei, I. & Lyden, D. Immune determinants of the pre-metastatic niche. Cancer Cell 41, 546\u2013572 (2023).","journal-title":"Cancer Cell"},{"key":"941_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg3551","volume":"6","author":"H du Bois","year":"2021","unstructured":"du Bois, H., Heim, T. A. & Lund, A. W. Tumor-draining lymph nodes: at the crossroads of metastasis and immunity. Sci. Immunol. 6, eabg3551 (2021).","journal-title":"Sci. Immunol."},{"key":"941_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12197","volume":"11","author":"N Leary","year":"2022","unstructured":"Leary, N. et al. Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes. J. Extracell. Vesicles 11, e12197 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"941_CR42","first-page":"12","volume":"18","author":"C Stringer","year":"2020","unstructured":"Stringer, C. et al. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 12\u201314 (2020).","journal-title":"Nat. Methods"},{"key":"941_CR43","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s10911-023-09552-y","volume":"28","author":"N Giotopoulou","year":"2023","unstructured":"Giotopoulou, N. et al. TGF\u00df1 stimulates lymphatic endothelial cells to produce IL7 and IL15, which act as chemotactic factors for breast cancer cells with mesenchymal properties. J. Mammary Gland Biol. Neoplasia 28, 2023\u201312-06 (2023).","journal-title":"J. Mammary Gland Biol. Neoplasia"}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00941-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00941-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00941-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:15:09Z","timestamp":1775564109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00941-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["941"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-00941-0","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}